Nanoworx bridges the gap between nanomedicine research and product development by offering specialized design, formulation, and characterization services. Their integrated approach and library production infrastructure accelerate the scaling of nanotherapeutics from concept to clinical application.
Funding
Funding not disclosed
Founders
Product
Problem
The translation of nanomedicine concepts into patient-ready products is hindered by a gap in specialized knowledge and manufacturing capabilities. This disconnect slows the development and scaling of innovative nanotherapeutics from academic research to clinical application.
Solution
Nanoworx addresses this challenge by providing expert services in nanomedicine design and fine-tuning, coupled with a library production infrastructure. This integrated approach accelerates the development lifecycle, enabling clients to efficiently scale their nanomedicine projects. By bridging the know-how and manufacturability gap, Nanoworx facilitates the transition of novel nanomedicines from conceptualization to tangible therapeutic solutions. Their services are tailored to meet specific client needs, streamlining the path to market for advanced nanomedical treatments.
Target Audience
The primary customers are pharmaceutical and biotechnology companies engaged in the development of nanomedicines, as well as academic research institutions seeking to translate their nanomedicine discoveries into viable products.
Features
- Specialized expertise in nanomedicine formulation and characterization
- Library production infrastructure to support scalable development
- Process optimization for nanomedicine manufacturing
- Assistance with nano-medicine design and fine-tuning
- Project management for expedited development timelines